Hamal, Sajad <br/><br/>
Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes: rationale and design of the semaglutide treatment on coronary progression trial.  [electronic resource] 

 -  Coronary artery disease  05 2020 
 - 306-314 p.  digital 
<br/><br/> Publication Type: Clinical Trial Protocol; Journal Article 
<br/><br/><label>ISSN: </label>1473-5830 
<br/><br/><label>Standard No.: </label>10.1097/MCA.0000000000000830  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Computed Tomography Angiography<br/>Coronary Angiography<br/>Coronary Artery Disease--complications<br/>Diabetes Mellitus, Type 2--complications<br/>Disease Progression<br/>Glucagon-Like Peptides--therapeutic use<br/>Humans<br/>Incretins--therapeutic use<br/>Plaque, Atherosclerotic--complications<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome<br/>Vascular Calcification--complications<br/>Glucagon-Like Peptide-1 Receptor Agonists